Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5-((2,4-diamino-5-pyrimidinyl)oxy)-4-isopropyl-2-methoxybenzenesulfonamide
2. Af-219
3. Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-
4. Mk-7264
1. 1015787-98-0
2. Af-219
3. Mk-7264
4. Gefapixant [usan]
5. Ro4926219
6. Rg-1646
7. Ro-4926219
8. Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-
9. 6k6l7e3f1l
10. R-1646
11. Af219
12. Rg1646
13. Mk-7264;af-219
14. R1646
15. 5-[(2,4-diaminopyrimidin-5-yl)oxy]-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamide
16. C14h19n5o4s
17. 5-((2,4-diaminopyrimidin-5-yl)oxy)-4-isopropyl-2-methoxybenzenesulfonamide
18. 5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide
19. 5-[(2,4-diamino-5-pyrimidinyl)oxy]-4-isopropyl-2-methoxybenzenesulfonamide
20. 5-((2,4-diaminopyrimidin-5-yl)oxy)-2-methoxy-4-(propan-2-yl)benzenesulfonamide
21. 5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide
22. Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-
23. 5-((2,4-diamino-5-pyrimidinyl)oxy)-4-isopropyl-2-methoxybenzenesulfonamide
24. Gefapixant [inn]
25. Gefapixant (usan/inn)
26. Gefapixant [who-dd]
27. Unii-6k6l7e3f1l
28. Gtpl9540
29. Schembl1493905
30. Chembl3716057
31. Dtxsid401337212
32. Amy27911
33. Bcp26079
34. Ex-a2788
35. Gefapixant(af-219,mk-7264)
36. Bdbm50533006
37. Mfcd24539325
38. S6664
39. Akos037515637
40. Zinc116342482
41. Db15097
42. Af-219; Mk-7264
43. Ac-35643
44. As-78086
45. Bm170818
46. Sy282739
47. Hy-101588
48. Cs-0021727
49. Ro 4926219
50. J3.556.891c
51. D11349
52. A934898
53. 2-methoxy-4-isopropyl-5-(2,4-diamino-5-pyrimidinyloxy)benzenesulfonamide
54. 5-(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonamide
55. Af9
Molecular Weight | 353.40 g/mol |
---|---|
Molecular Formula | C14H19N5O4S |
XLogP3 | 0.7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 5 |
Exact Mass | 353.11577528 g/mol |
Monoisotopic Mass | 353.11577528 g/mol |
Topological Polar Surface Area | 165 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 512 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
R - Respiratory system
R05 - Cough and cold preparations
R05D - Cough suppressants, excl. combinations with expectorants
R05DB - Other cough suppressants
R05DB29 - Gefapixant
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?